| | Publication Year | Title | Author(s) |
| 1 | 29-Mar-2009 | 11C-PiB PET studies in typical sporadic Creutzfeldt-Jakob disease. | Villemagne, Victor L ; McLean, Catriona A; Reardon, K; Boyd, A; Lewis, V; Klug, G; Jones, G; Baxendale, D; Masters, Colin L ; Rowe, Christopher C ; Collins, S J |
| 2 | 16-Sep-2009 | The 18F-FDG PET cingulate island sign and comparison to 123I-beta-CIT SPECT for diagnosis of dementia with Lewy bodies. | Lim, Seok Ming; Katsifis, Andrew; Villemagne, Victor L ; Best, Rene; Jones, Gareth; Saling, Michael M ; Bradshaw, Jennifer; Merory, John; Woodward, Michael M ; Hopwood, Malcolm; Rowe, Christopher C |
| 3 | 14-Feb-2008 | Abeta deposits in older non-demented individuals with cognitive decline are indicative of preclinical Alzheimer's disease. | Villemagne, Victor L ; Pike, Kerryn E; Darby, David G; Maruff, Paul; Savage, Greg; Ng, S ; Ackermann, Uwe ; Cowie, T F; Currie, J; Chan, S G; Jones, G; Tochon-Danguy, Henri; O'Keefe, Graeme J; Masters, Colin L ; Rowe, Christopher C |
| 4 | 1-Apr-2007 | The accuracy of cystatin C and commonly used creatinine-based methods for detecting moderate and mild chronic kidney disease in diabetes. | Macisaac, Richard J; Tsalamandris, Con; Thomas, Merlin C; Premaratne, Erosha ; Panagiotopoulos, Sianna ; Smith, T J; Poon, A ; Jenkins, Margaret A; Ratnaike, S I; Power, David Anthony; Jerums, George |
| 5 | 1-Sep-2000 | Albuminuria in patients with type 1 diabetes is directly linked to changes in the lysosome-mediated degradation of albumin during renal passage. | Osicka, Tanya M; Houlihan, Christine A ; Chan, J Gordon ; Jerums, George ; Comper, Wayne D |
| 6 | 1-Mar-2002 | Anti-renal cell carcinoma chimeric antibody G250: cytokine enhancement of in vitro antibody-dependent cellular cytotoxicity. | Liu, Zhanqi; Smyth, Fiona E; Renner, Christoph; Lee, Fook-Thean; Oosterwijk, Egbert; Scott, Andrew M |
| 7 | 15-Dec-2003 | Antitumor efficacy of cytotoxic drugs and the monoclonal antibody 806 is enhanced by the EGF receptor inhibitor AG1478. | Johns, Terrance G; Luwor, Rodney B; Murone, Carmel ; Walker, Francesca; Weinstock, Janet; Vitali, Angela A; Perera, Rushika M; Jungbluth, Achim A; Stockert, Elisabeth; Old, Lloyd J; Nice, Edouard C; Burgess, Antony W; Scott, Andrew M |
| 8 | 17-Mar-2005 | The antitumor monoclonal antibody 806 recognizes a high-mannose form of the EGF receptor that reaches the cell surface when cells over-express the receptor. | Johns, Terrance G; Mellman, Ira; Cartwright, Glenn A; Ritter, Gerd; Old, Lloyd J; Burgess, Antony W; Scott, Andrew M |
| 9 | 9-Aug-2008 | The ART of loss: Abeta imaging in the evaluation of Alzheimer's disease and other dementias. | Villemagne, Victor L ; Fodero-Tavoletti, Michelle T; Pike, Kerryn E; Cappai, Roberto; Masters, Colin L ; Rowe, Christopher C |
| 10 | 29-Apr-2008 | Assessing the impact of FDG-PET in the management of anal cancer. | Nguyen, Brandon T; Joon, Daryl Lim; Khoo, Vincent; Quong, George; Chao, Michael ; Wada, Morikatsu ; Joon, Michael Lim; See, Andrew; Feigen, Malcolm; Rykers, Kym; Kai, Cynleen; Zupan, Eddy; Scott, Andrew M |
| 11 | 1-Apr-2001 | Biodistribution properties of (111)indium-labeled C-functionalized trans-cyclohexyl diethylenetriaminepentaacetic acid humanized 3S193 diabody and F(ab')(2) constructs in a breast carcinoma xenograft model. | Tahtis, K; Lee, Fook-Thean; Smyth, Fiona E; Power, David Anthony; Renner, C; Brechbiel, Martin W; Old, Lloyd J; Hudson, P J; Scott, Andrew M |
| 12 | 8-Jun-2006 | Characterization of fluoromisonidazole binding in stroke. | Spratt, Neil J; Ackerman, Uwe; Tochon-Danguy, Henri J ; Donnan, Geoffrey A ; Howells, David William |
| 13 | 21-Jan-2009 | Characterization of PiB binding to white matter in Alzheimer disease and other dementias. | Fodero-Tavoletti, Michelle T; Rowe, Christopher C ; McLean, Catriona A; Leone, Laura; Li, Qiao-Xin; Masters, Colin L ; Cappai, Roberto; Villemagne, Victor L |
| 14 | 1-Sep-2001 | Clinical role of F-18 fluorodeoxyglucose positron emission tomography for detection and management of renal cell carcinoma. | Ramdave, S; Thomas, G W; Berlangieri, Salvatore U ; Bolton, Damien M ; Davis, Ian D; Danguy, H T; Macgregor, Duncan; Scott, Andrew M |
| 15 | 2005 | Comparison and Evaluation of PET/CT Image Registration. | Gong, Sylvia J; O'keefe, Graeme J; Scott, Andrew M |
| 16 | 1-Mar-2006 | Correlation of hypoxic cell fraction and angiogenesis with glucose metabolic rate in gliomas using 18F-fluoromisonidazole, 18F-FDG PET, and immunohistochemical studies. | Cher, Lawrence M ; Murone, Carmel ; Lawrentschuk, Nathan; Ramdave, Shanker; Papenfuss, Anthony; Hannah, Anthony; O'Keefe, Graeme J; Sachinidis, John I; Berlangieri, Salvatore U ; Fabinyi, Gavin C ; Scott, Andrew M |
| 17 | 1-Jun-2002 | Current status of positron emission tomography in oncology. | Scott, Andrew M |
| 18 | 7-Oct-2002 | Cytokine enhancement of in vitro antibody-dependent cellular cytotoxicity mediated by chimeric anti-GD3 monoclonal antibody KM871. | Liu, Zhanqi; Lee, Fook-Thean; Hanai, Nobuo; Smyth, Fiona E; Burgess, Antony W; Old, Lloyd J; Scott, Andrew M |
| 19 | 1-Jun-2004 | Detection of occult bone metastases of lung cancer with fluorine-18 fluorodeoxyglucose positron emission tomography. | Foo, Serene S; Ramdave, Shankar; Berlangieri, Salvatore U ; Scott, Andrew M |
| 20 | 15-Mar-2007 | The efficacy of epidermal growth factor receptor-specific antibodies against glioma xenografts is influenced by receptor levels, activation status, and heterodimerization. | Johns, Terrance G; Perera, Rushika M; Vernes, Sonja C; Vitali, Angela A; Cao, Diana; Cavenee, Webster K; Scott, Andrew M ; Furnari, Frank B |